Preoperative C-Reactive Protein-to-Albumin Ratio and Its Ability to Predict Outcomes of Pancreatic Cancer Resection: A Systematic Review.
Albumin
C-reactive protein
pancreatic cancer
prognostic score
Journal
Biomedicines
ISSN: 2227-9059
Titre abrégé: Biomedicines
Pays: Switzerland
ID NLM: 101691304
Informations de publication
Date de publication:
13 Jul 2023
13 Jul 2023
Historique:
received:
16
06
2023
revised:
04
07
2023
accepted:
11
07
2023
medline:
29
7
2023
pubmed:
29
7
2023
entrez:
29
7
2023
Statut:
epublish
Résumé
To evaluate the ability of the c-reactive protein-to-albumin ratio (CAR) in predicting outcomes in patients undergoing pancreatic cancer resection. A systematic search of electronic information sources and bibliographic reference lists was conducted. Survival outcomes and perioperative morbidity were the evaluated outcome parameters. Eight studies reporting a total of 1056 patients undergoing pancreatic cancer resection were identified. The median cut-off value for CAR was 0.05 (range 0.0003-0.54). Using multivariate analysis, all studies demonstrated that a higher CAR value was an independent and significant predictor of poor overall survival in patients undergoing pancreatic cancer resection. The estimated hazard ratio (HR) ranged from 1.4 to 3.6. Although there was a positive correlation between the reported cut-off values for CAR and HRs for overall survival, it was weak and non-significant (r = 0.36, Preoperative CAR value seems to be an important prognostic score in predicting survival outcomes in patients undergoing pancreatic cancer resection. However, the current evidence does not allow the determination of an optimal cut-off value for CAR, considering the heterogeneous reporting of cut-off values by the available studies and the lack of knowledge of their sensitivity and specificity. Future research is required.
Identifiants
pubmed: 37509622
pii: biomedicines11071983
doi: 10.3390/biomedicines11071983
pmc: PMC10377035
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Références
Medicine (Baltimore). 2020 Jun 5;99(23):e20595
pubmed: 32502031
Br J Surg. 2019 Mar;106(4):342-354
pubmed: 30758855
Hepatobiliary Pancreat Dis Int. 2014 Oct;13(5):474-81
pubmed: 25308357
Nutr Cancer. 1999;35(2):106-10
pubmed: 10693162
Surg Oncol. 2014 Mar;23(1):31-9
pubmed: 24378193
Eur J Med Res. 2020 Oct 7;25(1):46
pubmed: 33028394
Curr Opin Clin Nutr Metab Care. 2003 Jul;6(4):401-6
pubmed: 12806213
Oncotarget. 2018 Jan 8;9(6):6968-6976
pubmed: 29467943
PLoS One. 2017 Sep 8;12(9):e0184412
pubmed: 28886134
Medicine (Baltimore). 2019 Nov;98(48):e18219
pubmed: 31770284
Nutr J. 2010 Dec 22;9:69
pubmed: 21176210
Cancer Treat Rev. 2017 Jul;58:1-13
pubmed: 28602879
Cell. 2010 Mar 19;140(6):883-99
pubmed: 20303878
Ann Surg. 2004 Aug;240(2):293-8
pubmed: 15273554
BMJ. 2009 Jul 21;339:b2700
pubmed: 19622552
Asia Pac J Clin Oncol. 2019 Oct;15(5):e109-e114
pubmed: 30632282
World J Surg. 2016 Sep;40(9):2254-60
pubmed: 26956901
Br J Cancer. 2004 May 4;90(9):1704-6
pubmed: 15150622
Cancer. 2004 Dec 15;101(12):2727-36
pubmed: 15526319
J Pancreat Cancer. 2017 Jul 01;3(1):31-36
pubmed: 30631838
Int J Biol Sci. 2011;7(5):651-8
pubmed: 21647333
Sci Rep. 2017 Jun 7;7(1):2993
pubmed: 28592881
Surg Oncol. 2007 Jul;16(1):33-45
pubmed: 17544654
J Hepatocell Carcinoma. 2018 Jan 18;5:17-28
pubmed: 29404284
J Gastrointest Surg. 2006 Nov;10(9):1199-210; discussion 1210-1
pubmed: 17114007
CA Cancer J Clin. 2019 Jan;69(1):7-34
pubmed: 30620402
Int J Colorectal Dis. 2007 Aug;22(8):881-6
pubmed: 17245566
Br J Cancer. 2013 Jul 23;109(2):416-21
pubmed: 23799847
BMC Gastroenterol. 2020 Dec 14;20(1):423
pubmed: 33317455
World J Surg. 2014 Nov;38(11):2986-93
pubmed: 25104544
Biochem Med (Zagreb). 2016 Oct 15;26(3):297-307
pubmed: 27812299
Rev Recent Clin Trials. 2015;10(2):135-41
pubmed: 25778832
Nature. 2006 May 25;441(7092):431-6
pubmed: 16724054
Oncotarget. 2016 Nov 15;7(46):75013-75022
pubmed: 27738330
World J Gastrointest Oncol. 2016 Jul 15;8(7):555-62
pubmed: 27559435
In Vivo. 2020 Jan-Feb;34(1):347-353
pubmed: 31882498
Cancer Treat Rev. 2013 Aug;39(5):534-40
pubmed: 22995477
In Vivo. 2019 Nov-Dec;33(6):2071-2078
pubmed: 31662540
Oncotarget. 2017 Jun 20;8(25):41305-41318
pubmed: 28476041
Tumour Biol. 2016 Sep;37(9):12525-12533
pubmed: 27344157